Buy the full study
Summary of our market study
The French medical gases market is valued at over €1.5 billion.
The global medical gases market is valued at between $14 and $15 billion.
The French medical gases market is experiencing significant growth. These gases, essential in healthcare for the treatment and relief of pain, are part of the wider industrial gases sector.
Growing demand is mainly due to an ageing population, an increase in chronic diseases and improved access to healthcare.
The unforeseen increase in demand triggered by the COVID-19 pandemic played a major role in this
Spending on treatments such as continuous positive airway pressure and oxygen therapy rose from 400 million euros to over 800 million euros.
Medical gases for surgery and home healthcare show solid growth. Growth patterns are linked to an ageing population.
Medical gases are diverse and vital, ranging from inhaled gases such as oxygen and nitrous oxide to other gases used in various medical applications, such as laparoscopy and laser therapy.
A few international players dominate the market
- Air Liquide: Pillar of the industry and world leader in gases. Air Liquide Santé is the subsidiary specializing in the manufacture of medical gases. It has a growing international footprint.
- Air Products & Chemicals and Lida: This American conglomerate is another heavyweight in the sector, distributing a wide range of industrial gases
- Linde Healthcare: Offers a complete range of medical gases
- NOVAIR Medical: Innovative manufacturer and distributor of medical gases.
to understand this market
Detailed content of our market study
Inforamtion
- Number of pages : ~ 40 pages
- Format : Digital and PDF versions
- Last update :
Summary and extracts
1 Market overview
1.1 Definition and scope of study
Medical gases are mainly used in hospitals for treatment, pain relief, anesthesia and respiratory function.
The medical gases sub-segment is included in the broader industrial gases segment: manufactured gases produced by the distillation of air. These include oxygen, nitrogen, argon, helium, hydrogen, carbon dioxide and other rare gases. Thanks to their physical and chemical properties, they are used in the majority of industrial sectors: health (therapeutic gases for anesthesia, intensive care, pneumology, surgery, etc.), food and beverages (oxygen, nitrogen, argon, helium, hydrogen, carbon dioxide and other rare gases).), the food industry (soft drinks, for example), metallurgy, electronics, petrochemicals, etc.
Medical gases are grouped into three categories:
- Medicinal gases (Oxygen (O2), nitrous oxide (N2O), nitric oxide, etc.);
- Medical device gases (CO2, N2O, etc.);
- Non-status gases.
The medical gases market is dominated by international industrial gas producer and distributor groups, leaving very little room for new entrants. Most of the independent players have been bought out by the major groups, as part of their diversification strategies over the last 10 years. The various players in the medical gases sector are therefore players in the industrial gases sector more generally, who are focusing on international growth. This growth is achieved through the conquest of emerging markets and major R&D efforts.
The global medical gases market is estimated at 14.34 billion dollars in 2023and should record an average annual growth rate of8,30 %over the period 2024-2032, reaching a value of29.29 billion in 2032. [EMR]
The French market has also been dynamic and growing for several years. This growth is reflected in theincrease in AMO spending on medical gases: CPAP (Continuous Positive Airway Pressure) treatment with 862 million euros in 2021,oxygen therapy with 422 million euros and assisted ventilation devices with 320 million euros. [CEPS]
The French market leader is Air Liquide Santé - France, an Air Liquide subsidiary specializing in the manufacture of medical gases. This subsidiary reported sales of€166.79 million in 2021. The main challenge facing the market for medical gas producers is to be able to adapt to various contemporary issues, such as the increase in chronic diseases and global warming. [Air Liquide]
Growth is being driven in particular by an aging population and an increase in chronic diseases, combined with favorable government initiatives and better access to healthcare in developing countries. Finally, the Covid-19 pandemic has had a real positive impact on this market, considerably increasing demand for oxygen and other medical gases to treat the disease.
1.2 A growing global market
The global medical gases market is valued at $**.** billion in **** , and is expected to grow at a CAGR of *. **% over the period ****-****, reaching a value of $**.** billion in ****.
Estimated size of the medical gases market World, ****, in billions of US Source: ****
The market is therefore booming. This growth is notably ...
1.3 A healthy French market
Sales of medical gases are driven by consumption in the healthcare sector. Each year, the Comité économique des produits de santé (***), the French health products economic committee, reveals the reimbursable amounts for respiratory assistance in France. This data is a very good indicator of the size of the medical gases segment ...
1.4 Impact of Covid-19 on the sector
sales trends for industrial gas production activities
Industrial gas manufacturing activities are recorded in the Insee nomenclature under NAF code **.**Z: Manufacture of industrial gases. According to Insee, this sub-class includes :
The manufacture of liquefied or compressed inorganic industrial or medical gases: Elementary gases ; Liquid or compressed air ; Refrigerant gases ; Mixed ...
2 Demand analysis
2.1 Demographic trends should boost the sector
Global demographics
The United Nations predicts that by ****, the number of elderly people (***) in the world will have doubled, from *** million in **** to *.* billion. Their share of the world's population would thus increasefrom*,* % à **,* %.
France's aging population: already a reality...
Proportion of French population aged ** or over France, ****-****, in % Source: ****
...which ...
2.2 The uses of the main medical gases
Each medical gas can have different properties. According to Linde Healthcare France, there are three main uses for medical gases:
Therapeutic indications : use of the gas as a medicine; Specific medical use; Facilitating a medical/paramedical procedure.
According to the same source, we can draw up a table of the main ...
2.3 Different types of care requiring medical gases
Traditionally, medical gases are supplied to healthcare facilities including:
Hospitals ; ePHAD ; clinics.
Air Liquide supplies around **,*** hospitals and clinics with medical gases. Some laboratories also use them. Medical gases are also used in emergency medicine, particularly in first aid.
Many patients cared for by PSADs (***) require respiratory assistance:
The development of ...
2.4 Focus on a few pathologies requiring the use of medical gases
Acute pulmonary embolism
Number of cases of pulmonary embolism by age group France, ****, in number of cases Source: ****
The graph above represents the number of people treated for acute pulmonary embolism (***) in France in ****, by age group. In that year, around **,*** people aged ** and over were treated for pulmonary embolism, out ...
3 Market structure
3.1 Medical gas production: a sub-segment of industrial gas production
Sales of industrial gas production activities
The French industrial gas manufacturing business is listed by INSEE under the NAF **.**Znomenclature code: "Manufacture of industrial gases". INSEE gives this market size for ****: it amounted to *.** billion euros. This figure can be used to estimate the size of the medical imaging market in ...
3.2 Close proximity of production sites and high transport risks
Industrial gas production sites in France
TheUrssaf database also provides a regional breakdown of companies registered under NAF code **.**Z.
Medical gas production sites of major industrial gas groups
The most active medical gas production sites in France are often subsidiaries of major industrial gas groups.
The sector leader is the ...
3.3 Medical gas distribution networks
Medical gas distribution networks enable medical gases to be delivered in the best possible conditions, mainly to healthcare establishments (***), but also to laboratories.
In France, there are three players specializing in this type of service:
Tonnoir Fluides Médicaux RESOGAZ - Medical fluids and specialty gases for hospitals and laboratories MGM ...
3.4 The homecare market: a booming market for industry players
In ****, Les Echos estimated the home medical assistance market at €*.* billion, with an average annual growth rate of *% in recent years. According to the Fédération des prestataires de soins à domicile (***).
The Federation also gives a breakdown of these sales by activity, the * main segments being :
CPAP(***) ; oxygen therapy and ...
4 Offer analysis
4.1 Highly regulated product types
Three categories of medical gases
The omedit-paysdelaloire.fr website explains that medical gases are grouped into three categories:
Medicinal gases: (***) Ventilation, oxygenation, anesthesia, pain relief Oxygen (***)
The quality of medicinal gases is based on the specifications and methods of the European Pharmacopoeia monographs, where they exist, otherwise on those described in ...
4.2 Highly polluting products that will have to adapt to the energy transition
One of the sector's future challenges will be to integrate into the energy transition, with the use of less polluting products such as hydrogen.
A study published at the end of **** in The Lancet claimed that each surgical operation emits an average of between *** and *** kg of CO* due to a ...
5 Regulations
5.1 Strict standards
General regulations
The French Public Health Code (***) regulates the packaging and distribution of medical gases in France.
The regulations make it compulsory to
A label on the cylinder body identifying the gas contained; The presence of an instruction leaflet, as well as a Summary of Product Characteristics (***) in the case of ...
6 Positioning the players
6.1 Segmentation
- Faber Cylinders
- A.I.R Partenaire santé
- Spengler
- Gas Control Equipement
- Resogaz
- Mauger Gaz Médicaux (MGM)
- SOL
- Technologie médicale
- Linde
- Air Liquide
- Messer France
- Messer
- Air Products,7
- GCE (ESAB Groupe)
- Carbagas (Air Liquide)
- Vitalaire (AIR Liquide)
- Novair
List of charts presented in this market study
- Estimated medical gas market size
- Amount reimbursed on packages for the sectors concerned
- Population projections to 2070
- Proportion of French population aged 65 and over
- Size of the French industrial gas market
All our studies are available online in PDF format
Take a look at an example of our research on another market!
Latest news
Air Liquide, another key player in the world of semiconductors - 03/06/2024
- - Air Liquide holds a quarter of the world market for gases used in semiconductor production.
- - In 2023, this activity generated 2.5 billion euros in sales for Air Liquide, representing 9% of its annual revenues.
- - The global semiconductor market could reach $1,000 billion by 2030, up from $520 billion last year.
- - Last week, Air Liquide inaugurated a new production line in Sejong, south of Seoul, dedicated to the manufacture of diborane, a complex molecule demanded by the sector's giants.
- - Air Liquide's two recent projects in the semiconductor sector, including the opening of a new plant in Taiwan, represented an investment of $200 million.
Air Liquide buoyed by energy transition and electronics - 20/02/2024
- Sales of 27.61 billion euros in 2023.
- Gases and services account for 95% of revenues
- Air Liquide has generated growth worldwide.
- In hydrogen, investment of 400 million euros in the construction of Europe's largest electrolyzer, Normand'Hy
- Inauguration with Siemens Energy of an electrolyser gigafactory in Berlin.
- 200 million investment in two new advanced materials production centers in Taiwan and South Korea
- 140 million investment in the construction of an air separation unit in Quebec, specializing in electric batteries.
Hydrogen: Air Liquide to build a giant electrolyser in Normandy - 21/12/2023
- Electrolyser capacity in Normandy: 200 megawatts (MW)
- Planned hydrogen production: 80 tonnes / day
- Amount of Air Liquide project: 400 million euros (Subsidies received for the project: 190 million euros)
- Air Liquide sales: 30 billion euros
- Air Liquide's target for electrolysis capacity increase by 2030: 3 gigawatts (GW)
- Current production capacity of the Berlin gigafactory in partnership with Siements Energy: 1 GW
- Hydrogen production from an electrolyser in Canada starting up in 2021: 8.2 tonnes / day
- Electrolyser nearing completion in Oberhausen (Germany): 30 MW
- Air Liquide's hydrogen experience: 60 years with over 200 stations and 350 production units.
Siemens Energy and Air Liquide inaugurate their gigafactory to get green hydrogen off the ground - 09/11/2023
- Siemens Energy and Air Liquide's electrolyser Gigafactory in Berlin.
- It will produce cells with a total capacity of 1GW in the first year, gradually increasing to 3GW.
- Investment of 30 million euros
- it will power the hydrogen projects of Siemens Energy and Air Liquide, its only two customers.
- In Germany, Air Liquide will commission a 20 MW plant in the Ruhr, currently the largest in Europe.
- Another electrolyzer, ten times larger (200 MW), is planned: "Normand'Hy".
- It will supply green hydrogen to manufacturers in the Seine Valley. TotalEnergies has already reserved half the capacity.
- Air Liquide plans to have a portfolio of 3 GW by 2030.
- Air Liquide currently produces 1.2 million tonnes of hydrogen a year worldwide, but the overwhelming majority is still of fossil origin.
- "By 2030, grey hydrogen may account for only 50% of our business,
- The group plans to triple its sales by 2035, to 6 billion euros, taking advantage of the growth in low-carbon hydrogen.
- Germany sees hydrogen as one of the main vectors for decarbonization.
- Hydrogen infrastructure plan in the coming weeks - a 10,000-kilometer network
Air Liquide greenens its hydrogen - 31/07/2023
- Air Liquide's Port-Jérôme plant captures 100,000 tonnes of CO2 each year, more than 90% of the plant's emissions.
- Air Liquide has received 200 million euros from the French government to launch a hydrogen industry in Normandy.
- 95% of the natural gas consumed at Port-Jérôme is transformed into hydrogen.
- The Normand'Hy project involves an investment of 250 million euros to build a 200-megawatt electrolyzer.
- More than 680 "large-scale" hydrogen projects have been announced worldwide, representing a total investment of $240 billion.
Air Liquide: the springboard of the energy crisis - 16/02/2023
- The Group reported annual sales of 29.93 billion euros, the highest in its history
- Sales were driven by industrial merchant activities, in particular hydrogen and oxygen sales to the steel and chemical industries in Europe and the United States
- three new industrial gas production units for two major semiconductor manufacturers in Taiwan
- The Group has built its largest biomethane production unit in the United States
Companies quoted in this study
This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :
Choosing this study means :
Access to more than 35 hours of work
Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.
Benefit from 6 years' experience and over 1,500 industry reports already produced
Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.
Our know-how and methodology enable us to produce reports that offer unique value for money.
Access to several thousand articles and paid-for data
Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).
To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)
Guaranteed support after your purchase
A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676
A digital format designed for our users
Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.
Our offers :
the medical gases market | France
- What are the figures on the size and growth of the market?
- What is driving the growth of the market and its evolution?
- What is the positioning of companies in the value chain?
- Data from several dozen databases
Pack 5 études (-15%) France
- 5 études au prix de 75,6€HT par étude à choisir parmi nos 800 titres sur le catalogue France pendant 12 mois
- Conservez -15% sur les études supplémentaires achetées
- Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)
Consultez les conditions du pack et de remboursement des crédits non consommés.
Our customer references
They have consulted our studies
Discover the opinions (+500)
Malcolm Vincent
Astoria Finance
Gregoire de Castelnau
Stags Participations
Timothé Huignard
PWC
Paul-Alexis Kebabtchieff
BCG
Aymeric Granet
Publicis Consultant
interviews & case studies
All interviews and case studies (45)
